Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy.

Montopoli, M; Zorzi, M; Cocetta, V; Prayer-Galetti, T; Guzzinati, S; Bovo, E; Rugge, M; Calcinotto, A

Montopoli, M; Zorzi, M; Cocetta, V; Prayer-Galetti, T; Guzzinati, S; Bovo, E; Rugge, M; Calcinotto, A.

Affiliation

Montopoli M; Department of Pharmaceutical and Pharmacological Sciences, Università degli Studi di Padova, Padova, Italy; VIMM-Veneto Institute of Molecular Medicine, Fondazione per la Ricerca Biomedica Avanzata, Padova, Italy; Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland, Bell
Zorzi M; Veneto Tumour Registry, Azienda Zero, Padova, Italy.
Cocetta V; Department of Pharmaceutical and Pharmacological Sciences, Università degli Studi di Padova, Padova, Italy.
Prayer-Galetti T; Department of Oncological and Gastroenterological Sciences-Urology Unit, Azienda Ospedaliera di Padova, Padova, Italy.
Guzzinati S; Veneto Tumour Registry, Azienda Zero, Padova, Italy.
Bovo E; Veneto Tumour Registry, Azienda Zero, Padova, Italy.
Rugge M; Veneto Tumour Registry, Azienda Zero, Padova, Italy; Department of Medicine, Università degli Studi di Padova, Padova, Italy. Electronic address: massimo.rugge@unipd.it.
Calcinotto A; Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Università della Svizzera Italiana, Lugano, Switzerland. Electronic address: arianna.calcinotto@ior.usi.ch.

Ann Oncol ; 32(5): 676-677, 2021 05.

Article in En | MEDLINE | ID: mdl-33524477

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Breast Neoplasms / COVID-19 Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google